ARCH Venture Partners portfolio
ARCH Venture Partners (Venture capital) is known to hold 130 companies, 54 of them startups. 51 of them are hiring now, with 3,374 open roles. In the last 12 months rounds in the press named it 5 times (5 as the lead). Its companies closed 17 venture rounds in 12 months, raising $1.8B. Most of them work in Drug Discovery, Cell & Gene Therapy, Biologics & Biosimilars.
Companies ARCH Venture Partners has invested in
Open roles at ARCH Venture Partners portfolio companies
Focus
Co-investors
Similar investors
their companies share markets and countries
Questions about ARCH Venture Partners
How many companies has ARCH Venture Partners invested in?
ARCH Venture Partners is known to hold 130 companies: 54 startups, and 37 exits so far, read from its own portfolio page and the funding rounds that name it.
Is ARCH Venture Partners investing now?
Yes: in the last 12 months 5 rounds in the press named ARCH Venture Partners (5 as the lead), and 0 companies joined its portfolio page in 90 days.
What does ARCH Venture Partners invest in?
The markets of the companies ARCH Venture Partners holds: Drug Discovery (15%), Cell & Gene Therapy (8%), Biologics & Biosimilars (7%), Oncology Therapeutics (6%), Laboratory Equipment (5%).
Which ARCH Venture Partners portfolio companies are hiring?
51 companies ARCH Venture Partners holds are hiring now, with 3,374 open roles listed on this page.
Who does ARCH Venture Partners invest alongside?
The investors that hold the most companies together with ARCH Venture Partners: GV, F-Prime Capital, General Catalyst, EcoR1 Capital, Andreessen Horowitz.
How this page is made
A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.
Sources: its portfolio page, read Oct 18; 9 rounds in the press that name it
ARCH Venture Partners portfolio: 130 known companies. Alion, Oct 21, 2026. https://alion.io/company/arch-venture-partners/portfolio
